Gossamer Bio Ownership | Who Owns Gossamer Bio?
Gossamer Bio Ownership Summary
Gossamer Bio is owned by 77.46% institutional investors, 3.51% insiders, and 19.03% retail investors. Nea management company is the largest institutional shareholder, holding 7.96% of GOSS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.45% of its assets in Gossamer Bio shares.
GOSS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Gossamer Bio | 77.46% | 3.51% | 19.03% |
| Sector | Healthcare Stocks | 487.91% | 11.08% | -398.99% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nea management company | 18.09M | 7.96% | $22.25M |
| Blackrock funding, inc. /de | 12.14M | 5.34% | $14.94M |
| Vanguard group | 10.03M | 4.43% | $9.08M |
| Arch venture management | 8.06M | 3.54% | $9.91M |
| Fmr | 7.93M | 3.50% | $7.18M |
| Acadian asset management | 7.15M | 3.14% | $8.79M |
| 683 capital management | 6.34M | 2.79% | $7.80M |
| Samsara biocapital | 6.13M | 2.70% | $7.54M |
| Palo alto investors lp | 5.74M | 2.53% | $7.06M |
| Siren | 5.21M | 2.29% | $6.41M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Octagon capital advisors lp | 1.43M | 3.97% | $20.49M |
| Arch venture management | 8.06M | 3.31% | $9.91M |
| Nea management company | 18.09M | 1.68% | $22.25M |
| Samsara biocapital | 6.13M | 1.54% | $7.54M |
| Palo alto investors lp | 5.74M | 1.50% | $7.06M |
| Silverarc capital management | 5.15M | 1.17% | $6.33M |
| Exome asset management | 1.10M | 1.07% | $1.21M |
| Opaleye management | 4.29M | 1.05% | $4.72M |
| Monaco asset management sam | 3.55M | 0.77% | $4.37M |
| 683 capital management | 6.34M | 0.51% | $7.80M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 12.14M | 0.00% | 9.07M |
| Gsa capital partners llp | 862.41K | 0.06% | 794.87K |
| Acadian asset management | 7.15M | 0.02% | 787.91K |
| Colony group | 1.15M | 0.00% | 450.00K |
| Two sigma advisers, lp | 1.16M | 0.00% | 357.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | 1.43M | 3.97% | -16.93M |
| Ecor1 capital | - | - | -9.20M |
| Price t rowe associates inc /md/ | 64.78K | - | -6.37M |
| Farallon capital management | - | - | -6.13M |
| Madison avenue partners, lp | - | - | -4.14M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Merriman wealth management | 142.27K | 0.01% | 142.27K | $128.70K |
| Merit financial group | 134.69K | 0.00% | 134.69K | $354.23K |
| Alps advisors | 122.64K | 0.00% | 122.64K | $150.85K |
| Intech investment management | 98.30K | 0.00% | 98.30K | $120.91K |
| Quadrature capital | 95.80K | 0.00% | 95.80K | $116.87K |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -4.00 |
| Pfs partners | -50.00 |
| Northwestern mutual wealth management | -261.00 |
| Wells fargo & company/mn | -264.00 |
| Global retirement partners | -300.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 132 | 4.76% | 176,036,505 | 3.57% | 77 | 1.38% | 71 | 12.70% | 28 | -6.67% |
| Mar 31, 2025 | 23 | -79.82% | 67,155,072 | -60.80% | 29 | 0.52% | 7 | -85.11% | 6 | -77.78% |
| Dec 31, 2024 | 108 | 0.93% | 166,819,185 | -4.61% | 73 | 1.23% | 46 | 4.55% | 24 | -11.11% |
| Sep 30, 2024 | 107 | 7.00% | 174,874,925 | -4.36% | 77 | 1.18% | 44 | 7.32% | 27 | -10.00% |
| Jun 30, 2024 | 100 | -11.50% | 182,850,856 | -7.56% | 81 | 1.05% | 41 | -21.15% | 30 | -3.23% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 7.84M | 3.45% | - |
| Vanguard Total Stock Mkt Idx Inv | 6.80M | 2.99% | 33.18K |
| Fidelity Select Biotechnology | 5.45M | 2.40% | -2.13M |
| iShares Russell 2000 ETF | 4.65M | 2.04% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.04M | 0.90% | -932.41K |
| Fidelity Small Cap Index | 1.90M | 0.83% | 1.90M |
| iShares Russell 2000 Growth ETF | 1.69M | 0.74% | - |
| Fidelity Extended Market Index | 1.03M | 0.45% | -8.46K |
| Schwab US Small-Cap ETF™ | 929.69K | 0.41% | 2.38K |
| Vanguard Russell 2000 ETF | 908.06K | 0.40% | -58.84K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 19, 2025 | Milligan Sandra | - | Buy | $50.02K |
| Jun 24, 2024 | Aranda Richard | Chief Medical Officer | Sell | $1.26K |
| Jun 21, 2024 | Hasnain Faheem | President & CEO | Buy | $250.28K |
| Jun 18, 2024 | Giraudo Bryan | COO/CFO | Buy | $59.11K |
| Jun 17, 2024 | Smith Robert Paul JR | Chief Commercial Officer | Buy | $15.05K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q2 | 3 | 1 |
GOSS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools